'A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service'.

Perera, Padeepa; O'Donnabhain, Ronan; Fazio, Timothy; Johnson, Douglas; Lange, Peter

Perera, Padeepa; O'Donnabhain, Ronan; Fazio, Timothy; Johnson, Douglas; Lange, Peter.

Afiliação

Perera P; Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
O'Donnabhain R; Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Fazio T; Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Johnson D; Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Lange P; Department of General Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Clin Med Insights Cardiol ; 16: 11795468221133607, 2022.

Article em En | MEDLINE | ID: mdl-36329805

Palavras-chave

Sodium-glucose co-transporter-2 inhibitor; heart failure; type 2 diabetes mellitus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Med Insights Cardiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google